Imitrex Sc (Sumatriptan)

Sumatriptan works by stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This causes vasoconstriction of dilated intracranial vessels and blocks the release of inflammatory neuropeptides, thereby reducing pain signaling and migraine symptoms.

The prescribed dose of Imitrex Sc is determined by the treating physician based on the individual patient's clinical condition, severity of the migraine attack, and prior response to therapy. The healthcare professional will decide the appropriate amount and timing of each injection.

The safety of sumatriptan in pregnancy and lactation has not been definitively established. Healthcare providers should weigh the potential benefits against possible risks and consider alternative treatments when treating pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Imitrex Sc. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and required import documentation.

Imitrex Sc is a rapid‑acting injectable triptan, offering faster onset of relief compared with oral triptans, which must be absorbed through the gastrointestinal tract. It is particularly useful for patients who experience nausea or vomiting during migraine attacks or who need quick symptom control.

Imitrex Sc should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct light. Do not freeze. Check the label for the expiration date before use.

Imitrex Sc is given as a subcutaneous injection, typically into the outer thigh or abdomen. The injection is performed by a trained healthcare professional or by the patient after proper instruction. The device is a pre‑filled, single‑use syringe designed for easy administration.

Serious risks include coronary vasospasm leading to chest pain or myocardial ischemia, severe hypertension, serotonin syndrome when combined with other serotonergic agents, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience chest discomfort, severe hypertension, or signs of an allergic reaction.

Imitrex Sc is contraindicated in patients with known hypersensitivity to sumatriptan, those with uncontrolled hypertension, ischemic heart disease, severe coronary artery disease, or a history of stroke. It should also be avoided in patients who have taken ergotamine-containing medications within the previous 24 hours.